Is Human Enhancement also a Personal Matter?

Science and Engineering Ethics

Volumn 19, Issue 1, 2013, Pages 161-177

  Menuz, Vincent ^a   Hurlimann, Thierry ^a   Godard, Béatrice ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Biomedical enhancement; Enhancement technologies; Ethical issues; Genetic engineering

Indexed keywords

ARTICLE; ETHICS; HUMAN; MEDICAL TECHNOLOGY; NOMENCLATURE; PERCEPTION; SOCIAL PSYCHOLOGY;

BIOMEDICAL ENHANCEMENT; HUMANS; PERCEPTION; SOCIAL VALUES; TERMINOLOGY AS TOPIC;

EID: 84874570273     PISSN: 13533452     EISSN: 16605454     Source Type: Journal    
DOI: 10.1007/s11948-011-9294-y     Document Type: Article

References (82)

1. Adashi, E. Y., Cohen, J., Hamberger, L., Jones, H. W., Jr., de Kretser, D. M., Lunenfeld, B., et al. (2000). Public perception on infertility and its treatment: An international survey. Human Reproduction, 15(2), 330-334.
2. Allhoff, F., Lin, P., Moor, J., & Weckert, J. (2009). Ethics of human enhancement: 25 questions & answers. Studies in Ethics, Law, and Technology, 4(1), 4.
3. Anonymous. (2008). Defining 'natural'. Nature, 452(7188), 665-666.
4. Azzazy, H. M., Mansour, M. M., & Christenson, R. H. (2009). Gene doping: Of mice and men. Clinical Biochemistry, 42(6), 435-441.
5. Basl, J. (2010). State neutrality and the ethics of human enhancement technologies. AJOB Neuroscience, 1(2), 41-48.
6. Bell, K. (2006). An overview of assisted reproduction in Australia and directions for social research. Australian Journal of Emerging Technologies and Society, 4(1), 15-27.
7. Blackford, R. (2009). Moral pluralism versus the total view: Why singer is wrong about radical life extension. Journal of Medical Ethics, 35(12), 747-752.
8. Bostrom, N., & Roache, R. (2007). Ethical issues in human enhancement. In J. Ryberg, T. S. Petersen, & C. Wolf (Eds.), New waves in applied ethics. New York: Palgrave MacMillan.
9. Braude, P., Pickering, S., Flinter, F., & Ogilvie, C. M. (2002). Preimplantation genetic diagnosis. Nature Reviews Genetics, 3(12), 941-953.
10. Camporesi, S. (2008). Oscar pistorius, enhancement and post-humans. Journal of Medical Ethics, 34(9), 639.
11. Canton, J. (2003). The impact of convergent technologies and the future of business and the economy. In M. C. Roco & W. S. Bainbridge (Eds.), Converging technologies for improving human performance: Nanotechnology, biotechnology, information technology and cognitive science (pp. 71-78). Dordrecht, Netherlands: Kluwer.
12. Canton, J. (2004). Designing the future: NBIC technologies and human performance enhancement. Annals of the New York Academy of Sciences, 1013, 186-198.
13. Caplan, A. L. (2009). Good, better or best? In J. Savulescu & N. Bostrom (Eds.), Human enhancement (pp. 199-209). New York: Oxford University Press.
14. Cartier, N., Hacein-Bey-Abina, S., Bartholomae, C. C., Veres, G., Schmidt, M., Kutschera, I., et al. (2009). Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science, 326(5954), 818-823.
15. Chadwick, R. (2009). Therapy, enhancement and improvement. Medical Enhancement and Posthumanity, 2(I), 25-37.
16. Coenen, C., Schuijff, M., Smits, M., Klaassen, P., Hennen, L., Rader, M., et al. (2009). Human Enhancement: study. In Science and Technology Option Assessment (Ed.). Brussel: European Parliament.
17. Custers, R., & Aarts, H. (2010). The unconscious will: How the pursuit of goals operates outside of conscious awareness. Science, 329(5987), 47-50.
18. Daniels, N. (2000). Normal functioning and the treatment-enhancement distinction. Cambridge Quarterly of Healthcare Ethics, 9(3), 309-322.
19. de Melo-Martin, I. (2010). Defending human enhancement technologies: Unveiling normativity. Journal of Medical Ethics, 36(8), 483-487.
20. Devereaux, M. (2009). Cosmetic Surgery. Medical Enhancement and Posthumanity, 159-174.
21. Edwards, S. D. (2008). Should oscar pistorius be excluded from the 2008 olympic games? Sport Ethics and Philosophy, 2(2), 112-125.
22. Eisinger, F. (2007). Prophylactic mastectomy: Ethical issues. British Medical Bulletin, 81-82(1), 7-19.
23. Elliott, T. (2009). Body dysmorphic disorder, radical surgery and the limits of consent. Medical Law Review, 17(2), 149-182.
24. Finch, C. (2010). Secrets of a long life. Nature, 467(7313), 274-275.
25. Fontana, L., Partridge, L., & Longo, V. D. (2010). Extending healthy life span: From yeast to humans. Science, 328(5976), 321-326.
26. Gasson, M. N. (2010). Human Enhancement: Could you become infected with a computer virus? In 2010 IEEE International Symposium on Technology and Society, (pp. 61-68): IEEE.
27. George, S. M. (2006). Millions of missing girls: From fetal sexing to high technology sex selection in India. Prenatal Diagnosis, 26(7), 604-609.
28. Geraedts, J. P., & De Wert, G. M. (2009). Preimplantation genetic diagnosis. Clinical Genetics, 76(4), 315-325.
29. Gnoth, C., Godehardt, E., Frank-Herrmann, P., Friol, K., Tigges, J., & Freundl, G. (2005). Definition and prevalence of subfertility and infertility. Human Reproduction, 20(5), 1144-1147. doi: 10. 1093/humrep/deh870.
30. Graafstra, A. (2007). Hands on: How radio-frequency identification and I got personal. IEEE Spectrum, 44(3), 18-23.
31. Greely, H. T. (2005). Regulating human biological enhancements: Questionable justifications and international complications. University of Technology, Sydney, Law Review, 7, 87.
32. Greely, H. T. (2007). Remarks on human biological enhancement. University Kansas Law Review's, 56, 1139.
33. Haas, C. F., Champion, A., & Secor, D. (2008). Motivating factors for seeking cosmetic surgery: A synthesis of the literature. Plastic Surgical Nursing, 28(4), 177-182.
34. Harris, J. (2007). Enhancing evolution: The ethical case for making better people. Princeton, N. J.; Oxford: Princeton University Press.
35. Harvey, M. (2004). Reproductive autonomy rights and genetic disenhancement: Sidestepping the argument from backhanded benefit. Journal of applied philosophy, 21(2), 125-140.
36. Ho, A. (2008). The individualist model of autonomy and the challenge of disability. Journal of Bioethical Inquiry, 5(2), 193-207.
37. Ida, R. (2009). Should we improve human nature? An interrogation from an Asian perspective. In J. Savulescu & N. Bostrom (Eds.), Human enhancement (pp. 59-70). New York: Oxford University Press.
38. Ilbasmis-Tamer, S., Yilmaz, S., Banoglu, E., & Degim, I. T. (2010). Carbon nanotubes to deliver drug molecules. Journal of Biomedical Nanotechnology, 6(1), 20-27.
39. Jadad, A. R., & O'Grady, L. (2008). How should health be defined? British Journal of Medicine, 337, a2900.
40. Kamm, F. (2009). What is and is not wrong with enhancement? In J. Savulescu & N. Bostrom (Eds.), Human enhancement (pp. 91-130). New York: Oxford University Press.
41. Kitcher, P. (1997). The lives to come: The genetic revolution and human possibilities (Penguin science). London: Penguin.
42. Kline, R. (2009). Where are the Cyborgs in Cybernetics? Social Studies of Science, 39(3), 331.
43. Lanni, C., Lenzken, S. C., Pascale, A., Del Vecchio, I., Racchi, M., Pistoia, F., et al. (2008). Cognition enhancers between treating and doping the mind. Pharmacological Research, 57(3), 196-213.
44. Laos, C., & Metzl, J. D. (2006). Performance-enhancing drug use in young athletes. Adolescent Medicine Clinics, 17(3), 719-731.
45. Laure, P. (2002). Les conduites dopantes: Une prévention de l'échec? Psychotropes, 8(3), 31-38.
46. Lê-Germain, & Leca, R. (2005). Les conduites dopantes fondatrices d'une sous culture cycliste (1965-1999). Staps, 26(4), 109-125.
47. Lentillon-Kaestner, V. (2008). Conduites dopantes chez les jeunes cyclistes du milieu amateur au milieu professionnel. Psychotropes, 14(1), 41-57.
48. Lentillon-Kaestner, V., & Brissonneau, C. (2009). Appropriation progressive de la culture du dopage dans le cyclisme. Déviance et Société, 33(4), 519-541.
49. Lin, P., & Allhoff, F. (2008). Untangling the debate: The ethics of human enhancement. NanoEthics, 2(3), 251-264.
50. Mansour, M. M., & Azzazy, H. M. (2009). The hunt for gene dopers. Drug Testing and Analysis, 1(7), 311-322.
51. McKanna, T. A., & Toriello, H. V. (2010). Gene doping: The hype and the harm. Pediatric Clinics of North America, 57(3), 719-727.
52. McKean, E. (Ed.). (2005). The new oxford American dictionary (2nd ed.). Oxford: Oxford University Press.
53. Missa, J. N., & Perbal, L. (Eds.). (2009). Enhancement: Éthique et philosophie de la médecine d'amélioration. Paris: Vrin.
54. Nordmann, A. (2007). If and then: A critique of speculative nanoethics. NanoEthics, 1(1), 31.
55. Ogilvie, C. M., Braude, P. R., & Scriven, P. N. (2005). Preimplantation genetic diagnosis: An overview. Journal of Histochemistry and Cytochemistry, 53(3), 255-260.
56. Omer, S. B., Salmon, D. A., Orenstein, W. A., deHart, M. P., & Halsey, N. (2009). Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases. New England Journal of Medicine, 360(19), 1981-1988.
57. Parens, E. (1998). Is better always good? The enhancement project. The Hastings Center Report, 28(1), S1-S15.
58. President's Council on Bioethics. (2003). Beyond therapy: Biotechnology and the pursuit of happiness. Washington, DC: Dana Press.
59. Roco, M. C. (2004). Science and technology integration for increased human potential and societal outcomes. Annals of the New York Academy of Sciences, 1013, 1-16.
60. Roco, M. C., & Bainbridge, W. S. (Eds.). (2003). Converging technologies for improving human performance: Nanotechnology, biotechnology, information technology and cognitive science. Dordrecht, Netherlands: Kluwer.
61. Rothman, S. M., & Rothman, D. J. (2004). The pursuit of perfection: The promise and perils of medical enhancement. New York: Vintage.
62. Ryan, C. J. (2009). Out on a limb: The ethical management of body integrity identity disorder. Neuroethics, 2(1), 21-33.
63. Sadler, J. Z. (2010). Dignity, arete, and hubris in the transhumanist debate. The American Journal of Bioethics, 10(7), 67-68.
64. Sandel, M. J. (2004). The case against perfection: Ethics in the age of genetic engineering. USA: Harvard University Press.
65. Savulescu, J. (2006). Justice, fairness, and enhancement. Annals of the New York Academy of Sciences, 1093, 321-338.
66. Schneider, A. J. (2006). Cultural nuances: Doping, cycling and the tour de France. Sport in Society, 9(2), 212-226.
67. Shamloul, R. (2010). Natural aphrodisiacs. Journal of Sexual Medicine, 7(1 Pt 1), 39-49.
68. Spence, S. A. (2008). Can pharmacology help enhance human morality? The British Journal of Psychiatry, 193(3), 179-180.
69. Spinney, L. (2006). Gerontology: Eat your cake and have it. Nature, 441(7095), 807-809.
70. Spriggs, M. (2002). Lesbian couple create a child who is deaf like them. Journal of Medical Ethics, 28(5), 283.
71. ter Meulen, R. (2010). Dignity, posthumanism, and the community of values. The American Journal of Bioethics, 10(7), 69-70. doi: 10. 1080/15265161003728852.
72. The Irish Council for Bioethics. (2007). Human enhancement: Making people better or making better people. Human Enhancement Information Leaflet.
73. Turner, L. (2004). Biotechnology, bioethics and anti-aging interventions. Trends in Biotechnology, 22(5), 219-221.
74. van den Heuvel, M. G., & Dekker, C. (2007). Motor proteins at work for nanotechnology. Science, 317(5836), 333-336.
75. van Hilvoorde, I., & Landeweerd, L. (2010). Enhancing disabilities: Transhumanism under the veil of inclusion? Disability and Rehabilitation, 32(26), 2222-2227. doi: 10. 3109/09638288. 2010. 491578.
76. Weinberg, M. A., & Insler, M. S. (2010). LASIK refractive eye surgery in the 21st century. US Pharmacist, 4, 20-24.
77. Weir, K., & Keegan, M. (2010). Girl to have leg amputated to become Paralympian. Manchester evening news. http://menmedia. co. uk/manchestereveningnews/news/s/1301780_girl_to_have_leg_amputated_to_become_paralympian. Accessed 24th July 2010.
78. Wenning, L., & Cruz, R. (2006). The ethics of artificial vision technology: An early step towards an ethics of cybernetic repair and augmentation. Columbia University Journal of Bioethics, V(1), 59-64.
79. Wijsbek, H. (2000). The pursuit of beauty: The enforcement of aesthetics or a freely adopted lifestyle? Journal of Medical Ethics, 26(6), 454-458.
80. Williams, E. A. (2006). Good, better, best: The human quest for enhancement. Washington, DC: American Association for the Advancement of Science.
81. Wolfe, R. M., & Sharp, L. K. (2002). Anti-vaccinationists past and present. British Journal of Medicine, 325(7361), 430-432.
82. Wolpe, P. R. (2002). Treatment, enhancement, and the ethics of neurotherapeutics. Brain and Cognition, 50(3), 387-395.